Legal - Pharmaceutical Executive

ADVERTISEMENT

Legal
New legislation, key court cases, and trends affecting patents, marketing, privacy, product liability, and more.

A Rule of Thumb Gets Shot Down

March 1, 2011

The Federal Circuit court continues its trend in tightening the standards for establishing patent damages by leapfrogging a stalled legislative process

US Anti-Corruption Regulation Risks

December 1, 2010

Stepped-up enforcement of the Foreign Corrupt Practices Act requires enhanced global coordination of compliance

Three Little Pigs of Deceptive Advertising

September 1, 2010

If companies aren't careful with their marketing spend, they could, in fact, wind up getting too much bang for their buck

Patenting Diagnostics: Going Back to the Drawing Board

August 1, 2010

A recent Supreme Court decision leaves open the debate on patent eligibility requirements.

Part 4: Post-Employment Restrictive Covenants

April 29, 2009

The final part in our series on how to draft enforceable post-employment restriction agreements that will protect trade secrets and customer goodwill.

Part 3: How to Enforce Post-Employment Restrictions

April 22, 2009

Courts are often hesitant to enforce such restrictions, so employers should take certain steps prior to and in the process of filing such a lawsuit.

Part 2: Post-Employment Restrictive Covenants

April 15, 2009

How to draft enforceable post-employment restriction agreements that will protect trade secrets and customer goodwill.

Mind the (Tax) Gap

April 1, 2008

A little-known provision in a new law rewards employees for blowing the whistle on tax fraud. Pharma should examine its tricky tax situation—and work out the issues on a global level.

Arkansas Attorney General Takes J&J to Task

December 5, 2007

The State of Arkansas filed suit against Risperdal manufacturer Johnson & Johnson, claiming promotion of the drug for nonmedical uses has led to increased prescriptions being written and bigger payouts by Medicaid.

ADVERTISEMENT

Click here